Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9N1Y

BSEP E297G Apo Structure in GDN

Summary for 9N1Y
Entry DOI10.2210/pdb9n1y/pdb
EMDB information48824
DescriptorBile salt export pump (1 entity in total)
Functional Keywordsbsep, abcb11, membrane protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight146485.33
Authors
Reddy, B.G.,Gruget, C.,Moore, J. (deposition date: 2025-01-27, release date: 2025-04-02, Last modification date: 2025-05-28)
Primary citationGruget, C.,Reddy, B.G.,Moore, J.M.
A structural and mechanistic model for BSEP dysfunction in PFIC2 cholestatic disease.
Commun Biol, 8:531-531, 2025
Cited by
PubMed Abstract: BSEP (ABCB11) transports bile salts across the canalicular membrane of hepatocytes, where they are incorporated into bile. Biallelic mutations in BSEP can cause Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC2), a rare pediatric disease characterized by hepatic bile acid accumulation leading to hepatotoxicity and, ultimately, liver failure. The most frequently occurring PFIC2 disease-causing mutations are missense mutations, which often display a phenotype with decreased protein expression and impaired maturation and trafficking to the canalicular membrane. To characterize the mutational effects on protein thermodynamic stability, we carried out biophysical characterization of 13 distinct PFIC2-associated variants using in-cell thermal shift (CETSA) measurements. These experiments reveal a cluster of residues localized to the NBD2-ICL2 interface, which exhibit severe destabilization relative to wild-type BSEP. A high-resolution (2.8 Å) cryo-EM structure provides a framework for rationalizing the CETSA results, revealing a novel, NBD2-localized mechanism through which the most severe missense patient mutations drive cholestatic disease. These findings suggest potential strategies for identifying mechanism-based small molecule correctors to address BSEP trafficking defects and advance novel therapies for PFIC2 and other cholestatic diseases.
PubMed: 40195555
DOI: 10.1038/s42003-025-07908-0
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.23 Å)
Structure validation

236620

건을2025-05-28부터공개중

PDB statisticsPDBj update infoContact PDBjnumon